AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 1 filers reported holding AMRYT PHARMA PLC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Athyrium Capital Management, LP | 8,857,268 | $61,292,000 | 22.96% |
Stonepine Capital Management, LLC | 6,227,733 | $43,096,000 | 19.37% |
MPM ASSET MANAGEMENT LLC | 2,668,843 | $18,468,000 | 7.03% |
Aquilo Capital Management, LLC | 1,998,993 | $13,833,000 | 4.99% |
New Leaf Venture Partners, L.L.C. | 449,737 | $3,112,000 | 1.85% |
Global Frontier Investments LLC | 505,000 | $3,495,000 | 1.77% |
Rubric Capital Management LP | 3,600,000 | $24,912,000 | 1.26% |
Telemetry Investments, L.L.C. | 123,000 | $851,000 | 1.09% |
Nantahala Capital Management | 1,437,458 | $9,947,000 | 0.64% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 6,333,552 | $43,828,000 | 0.62% |